This post is from the non-Dechert side of the blog
Not long ago, one of our co-bloggers fielded some correspondence that, distilled from its abundant rhetoric, seemed to criticize a blog post for its defense-leaning bias. Given this, we hasten to reiterate, before we begin today’s post, that this is a defense blog. We are
We have tried to be pretty balanced in addressing a number of decisions over the last few months relating to lawsuits brought by the euphemistically labeled “vaccine hesitant” and their brethren who advocate aggressively for entitlement to “alternative” medical treatments like anti-parasitic (veterinary) drugs. We have been restrained in treating these lawsuits as having been
Happy Birthday to the Drug and Device Law Daughter. You cannot come home from Kyrgyzstan soon enough. Fall might be the season of mists and mellow fruitfulness, but it is dismal without you. And we hope you have refrained from playing Buzkashi (headless goat polo).
****************************
Sometimes we discern patterns in our posts. Last week
Today’s decision strays from the field of prescription drug/device law, but we take this detour because Aybar v. Aybar, 2021 N.Y. LEXIS 2134 (N.Y. Ct. App. Oct. 7, 2021) is an important jurisdictional decision – one with over 100 years of legal precedent to sort out.
Plaintiffs were involved in an automobile accident in
Some things were never meant to go together. Oil and water. Ice cream and ketchup. Harry Potter and Lord Voldemort (although fans of the books will quickly point out that Boy Who Lived was actually linked inextricably to his arch enemy). Picnics and honey bees. Elected officials and the power to borrow money. You get
Yesterday, we published an excellent synopsis of Iowa law concerning the learned intermediary rule, written by Iowa lawyers with a in-depth feel for their own state’s law, including useful analogies. They have produced the most comprehensive argument we’ve seen why their home state’s supreme court should adopt the rule.
According to our 50-state learned intermediary
Today’s guest post comes from Iowa born and bred attorney Stephanie Koltookian along with Tom Joensen and Tom Kus, all of Faegre Drinker. The backstory is that Stephanie sent Bexis a note that the Blog should not just necessarily assume that Iowa would adopt the learned intermediary rule, since the state’s high court
For the second time in three weeks a court has denied an injunction that would have compelled a hospital to administer ivermectin to a patient seriously ill with COVID-19. We previously reported on the first of those decisions, Smith v. West Chester Hosp., LLC, 2021 WL 4129083 (Ohio Com. Pl. 2021). Today we report
The Drug and Device Law Daughter has told us more than once that the future will see a vast expansion of animal rights. Animals are capable of suffering, and even if they will never be accorded the exact same civil rights as people (who are, after all, also animals), surely we will find ways to
We aren’t going to beat around the bush today – the facts of Paulsen v. Abbott Laboratories, 2021 WL 4439408 (N.D. Ill. Sept. 28, 2021) are straightforward and so too will we be. This case is largely about the chronology, so here it is: